VANI vs. SMTI, NYXH, ZIMV, STIM, SNWV, TCMD, NVRO, DRTS, SKIN, and TLSI
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Sanara MedTech (SMTI), Nyxoah (NYXH), ZimVie (ZIMV), Neuronetics (STIM), SANUWAVE Health (SNWV), Tactile Systems Technology (TCMD), Nevro (NVRO), Alpha Tau Medical (DRTS), Beauty Health (SKIN), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.
Vivani Medical vs. Its Competitors
Sanara MedTech (NASDAQ:SMTI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, community ranking, media sentiment and dividends.
Sanara MedTech has higher revenue and earnings than Vivani Medical. Sanara MedTech is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Sanara MedTech had 5 more articles in the media than Vivani Medical. MarketBeat recorded 7 mentions for Sanara MedTech and 2 mentions for Vivani Medical. Sanara MedTech's average media sentiment score of 1.03 beat Vivani Medical's score of 0.63 indicating that Sanara MedTech is being referred to more favorably in the media.
Sanara MedTech currently has a consensus price target of $49.50, suggesting a potential upside of 71.04%. Vivani Medical has a consensus price target of $4.00, suggesting a potential upside of 236.13%. Given Vivani Medical's higher probable upside, analysts clearly believe Vivani Medical is more favorable than Sanara MedTech.
Sanara MedTech received 17 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 61.54% of users gave Sanara MedTech an outperform vote.
Vivani Medical has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Vivani Medical's return on equity.
8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 46.4% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Sanara MedTech has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.93, indicating that its share price is 193% more volatile than the S&P 500.
Summary
Sanara MedTech beats Vivani Medical on 10 of the 16 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 6/12/2025 by MarketBeat.com Staff
